The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Prediman K. Shah

Division of Cardiology and Oppenheimer Atherosclerosis Research Center

Cedars Sinai Heart Institute

Suite 5531

Cedars Sinai Medical Center

USA

[email]@cshs.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cardiology and Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute, Suite 5531, Cedars Sinai Medical Center, USA. 1999 - 2011
  • Division of Cardiology and Atherosclerosis Research Center, Burns and Allen Research Institute and Department of Medicine, Cedars Sinai Medical Center and UCLA School of Medicine, Los Angeles, USA. 2003 - 2007
  • Cedars Sinai Medical Center, Cardiology Division, Suite 5347, 8700 Beverly Blvd, USA. 2004
  • Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA. 2003

References

  1. Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL. Shah, P.K. Nat. Rev. Cardiol (2011) [Pubmed]
  2. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL. Shah, P.K. Curr. Opin. Cardiol. (2010) [Pubmed]
  3. The SHAPE paradigm: a commentary. Shah, P.K. Circ. Cardiovasc. Qual. Outcomes (2010) [Pubmed]
  4. Inflammation and plaque vulnerability. Shah, P.K. Cardiovasc. Drugs. Ther (2009) [Pubmed]
  5. Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach. Shah, P.K. Curr. Pharm. Des. (2007) [Pubmed]
  6. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease. Shah, P.K. Eur. Heart J. (2007) [Pubmed]
  7. Emerging HDL-based Therapies for Atherothrombotic Vascular Disease. Shah, P.K. Curr. Treat. Options. Cardiovasc. Med (2007) [Pubmed]
  8. Molecular mechanisms of plaque instability. Shah, P.K. Curr. Opin. Lipidol. (2007) [Pubmed]
  9. Insights into the molecular mechanisms of plaque rupture and thrombosis. Shah, P.K. Indian. Heart. J (2005) [Pubmed]
  10. Apolipoprotein A-I mimetic peptides: potential role in atherosclerosis management. Shah, P.K., Chyu, K.Y. Trends Cardiovasc. Med. (2005) [Pubmed]
  11. Immunomodulation of atherosclerosis with a vaccine. Shah, P.K., Chyu, K.Y., Fredrikson, G.N., Nilsson, J. Nature Clinical Practice. Cardiovascular Medicine (2005) [Pubmed]
  12. Vaccination for atherosclerosis: a novel therapeutic paradigm. Shah, P.K., Chyu, K.Y., Fredrikson, G.N., Nilsson, J. Expert. Rev. Vaccines (2004) [Pubmed]
  13. Mechanisms of plaque vulnerability and rupture. Shah, P.K. J. Am. Coll. Cardiol. (2003) [Pubmed]
  14. Myocardial infarction and ischemia. Shah, P.K. J. Am. Coll. Cardiol. (2003) [Pubmed]
  15. Pathophysiology of plaque rupture and the concept of plaque stabilization. Shah, P.K. Cardiol. Clin (2003) [Pubmed]
  16. Chronic infections and atherosclerosis/thrombosis. Shah, P.K. Curr. Atheroscler. Rep (2002) [Pubmed]
  17. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Shah, P.K., Yano, J., Reyes, O., Chyu, K.Y., Kaul, S., Bisgaier, C.L., Drake, S., Cercek, B. Circulation (2001) [Pubmed]
  18. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Shah, P.K., Kaul, S., Nilsson, J., Cercek, B. Circulation (2001) [Pubmed]
  19. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II. Shah, P.K., Kaul, S., Nilsson, J., Cercek, B. Circulation (2001) [Pubmed]
  20. Focus on HDL: a new treatment paradigm for athero-thrombotic vascular disease. Shah, P.K. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  21. Plaque disruption and thrombosis. Potential role of inflammation and infection. Shah, P.K. Cardiol. Clin (1999) [Pubmed]
 
WikiGenes - Universities